AZN (AZN) Stock Analysis

AZN (AZN) is a publicly traded company in the HEALTHCARE sector. It trades at $177.46, carries a market capitalization of $287.95B, a price-to-earnings ratio of 27.92, a dividend yield of 0.02%. This page summarizes the public market data, fundamentals, and frequently asked questions for AZN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NASDAQ

Key Metrics

• Price: $177.46
• Market Cap: $287.95B
• P/E Ratio: 27.92
• EPS: $6.65
• Dividend Yield: 0.02%
• 52-Week High: $210.50
• 52-Week Low: $134.85

Market Sentiment

AZN currently has a Bullish sentiment score of 0.26.

About AZN

AstraZeneca PLC is a leading global biopharmaceutical company based in Cambridge, UK, that focuses on the discovery, development, and commercialization of innovative prescription medicines across diverse therapeutic areas, including oncology, cardiovascular, renal, respiratory, and neuroscience. With a strong pipeline of candidates and an unwavering commitment to addressing unmet medical needs, AstraZeneca employs cutting-edge scientific research and strategic partnerships to advance its grow...

GNG Research Analysis

GNG Research scores AZN (AZN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for AZN.

Frequently Asked Questions

What is AZN's current dividend yield?

AZN (AZN) has a current dividend yield of 0.02%.

Does AZN pay dividends?

Yes, AZN pays dividends with a current yield of 0.02%.

What is AZN's P/E ratio?

AZN has a price-to-earnings (P/E) ratio of 27.92.

What is AZN's market cap?

AZN (AZN) has a market capitalization of $287.95B with a current stock price of $177.46.